Olanta Theophilos-Negeri, PhD

Olanta Theophilos-Negeri, PhD is a Business Analyst with experience covering CI projects across indications including infectious disease, gynecological cancers, and kidney rare diseases. Olanta completed her PhD research at the University of Ottawa focusing on mechanisms of post-transcriptional gene expression control in neurodegeneration and peripheral inflammation relevant to Parkinson’s Disease. Olanta also spent time in Venture Capital evaluating therapeutics for psychiatric and neurological disease. She also has experience in technology transfer where she managed intellectual property and commercialization of biomedical research at the University of Ottawa.